Stock A176750 DUCHEMBIO CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News DuChemBIO Co.,Ltd.

Equities

A176750

KR7176750008

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 19/05/2024 BST 		5-day change 1st Jan Change
6,960 KRW -0.43% Intraday chart for DuChemBIO Co.,Ltd. -3.33% +26.55%
2020 Telix Pharmaceuticals Limited Enters into A Commercialisation and Partnership Agreement with Duchembio Co, Ltd CI
2020 Radiopharmaceutical Business Division of CareCamp Inc. agreed to acquire DuChemBIO Co.,Ltd. from Kim Jong-woo and others, in a reverse merger transaction for approximately KRW 210 billion. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Telix Pharmaceuticals Limited Enters into A Commercialisation and Partnership Agreement with Duchembio Co, Ltd
CI
Radiopharmaceutical Business Division of CareCamp Inc. agreed to acquire DuChemBIO Co.,Ltd. from Kim Jong-woo and others, in a reverse merger transaction for approximately KRW 210 billion.
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 4.5 billion in funding from RNR Partners Group Co., Ltd., YNK Company Inc.
CI
DuChemBIO Co.,Ltd. announced that it expects to receive KRW 4.5 billion in funding from RNR Partners Group Co., Ltd., YNK Company Inc.
CI
ITM Isotopen Technologien München and DuChemBio Sign Exclusive Licensing & Development Agreement for Solucin® TRT in South Korea
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 5.37897425 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co.,Ltd., Korea Development Bank, Investment Arm, Komelon Corporation
CI
DuChemBIO Co.,Ltd. announced that it expects to receive KRW 5.37897425 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co.,Ltd., Korea Development Bank, Investment Arm, Komelon Corporation
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 2.99996 billion in funding
CI
DuChemBIO Co.,Ltd. announced that it expects to receive KRW 2.99996 billion in funding
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 999.994 million in funding from Korea Investment & Securities Co., Ltd., Investment Arm
CI
DuChemBIO Co.,Ltd. announced that it expects to receive KRW 999.994 million in funding from Korea Investment & Securities Co., Ltd., Investment Arm
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 1.299994 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm
CI
DuChemBIO Co.,Ltd. announced that it expects to receive KRW 1.299994 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 3 billion in funding
CI
DuChemBIO Co.,Ltd. announced that it expects to receive KRW 3 billion in funding
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 2 billion in funding from Asam Asset Management Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm
CI
DuChemBio Co., Ltd. announced that it has received KRW 3 billion in funding.
CI
DuChemBio Co., Ltd. announced that it expects to receive KRW 3 billion in funding.
CI
DuChemBio Co., Ltd. announced that it has received KRW 2 billion in funding from Mega Investment Co., Ltd., ASAM Investment Advisory Company Limited.
CI
Duchem Bio Co., Ltd. announced that it expects to receive KRW 2 billion in funding from Mega Investment Co., Ltd., ASAM Investment Advisory Company Limited, and another investor.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A176750 Stock
  4. News DuChemBIO Co.,Ltd.